These final results, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of focusing on ACKR3 as a novel strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated disorders. Name your assortment: Identify https://heinzh406izq3.thekatyblog.com/profile